DK143755C - Analogifremgangsmaade til fremstilling af peptidphosphonsyrederivater eller salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af peptidphosphonsyrederivater eller salte deraf

Info

Publication number
DK143755C
DK143755C DK29576A DK29576A DK143755C DK 143755 C DK143755 C DK 143755C DK 29576 A DK29576 A DK 29576A DK 29576 A DK29576 A DK 29576A DK 143755 C DK143755 C DK 143755C
Authority
DK
Denmark
Prior art keywords
peptid
analogue
salts
preparing
acid derivatives
Prior art date
Application number
DK29576A
Other languages
Danish (da)
English (en)
Other versions
DK143755B (da
DK29576A (da
Inventor
F R Atherton
M J Hall
C H Hassall
R W Lambert
P S Ringrose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3417/75A external-priority patent/GB1533239A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK29576A publication Critical patent/DK29576A/da
Publication of DK143755B publication Critical patent/DK143755B/da
Application granted granted Critical
Publication of DK143755C publication Critical patent/DK143755C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10Alpha-amino-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK29576A 1975-01-27 1976-01-26 Analogifremgangsmaade til fremstilling af peptidphosphonsyrederivater eller salte deraf DK143755C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB341775 1975-01-27
GB3417/75A GB1533239A (en) 1975-01-27 1975-01-27 Peptide derivatives of phosphonic and phosphinic acids
GB4778775 1975-11-20
GB4778775 1975-11-20

Publications (3)

Publication Number Publication Date
DK29576A DK29576A (da) 1976-07-28
DK143755B DK143755B (da) 1981-10-05
DK143755C true DK143755C (da) 1982-03-22

Family

ID=26238285

Family Applications (1)

Application Number Title Priority Date Filing Date
DK29576A DK143755C (da) 1975-01-27 1976-01-26 Analogifremgangsmaade til fremstilling af peptidphosphonsyrederivater eller salte deraf

Country Status (26)

Country Link
US (1) US4016148A (ja)
JP (1) JPS598278B2 (ja)
AR (1) AR218850A1 (ja)
AT (1) AT359217B (ja)
AU (1) AU502919B2 (ja)
BR (1) BR7600449A (ja)
CA (1) CA1065857A (ja)
CH (2) CH624965A5 (ja)
DD (1) DD123756A5 (ja)
DE (1) DE2602193C2 (ja)
DK (1) DK143755C (ja)
DO (1) DOP1976002544A (ja)
ES (1) ES444622A1 (ja)
FI (1) FI61032C (ja)
FR (1) FR2298335A1 (ja)
GR (1) GR58609B (ja)
HU (1) HU176800B (ja)
IE (1) IE42466B1 (ja)
IL (1) IL48835A (ja)
LU (1) LU74249A1 (ja)
NL (1) NL177021C (ja)
NO (1) NO146429C (ja)
PH (1) PH16560A (ja)
PL (1) PL99096B1 (ja)
PT (1) PT64743B (ja)
SE (2) SE424328B (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1577232A (en) * 1976-05-14 1980-10-22 Roche Products Ltd Peptide derivatives of phosphonic and phosphinic acids
FR2351125A1 (fr) * 1976-05-14 1977-12-09 Hoffmann La Roche Derives peptidiques et procede pour leur preparation
IT1081511B (it) * 1976-07-13 1985-05-21 Hoffmann La Roche Derivati di peptidi e loro preparazione
GB1585076A (en) * 1976-07-13 1981-02-25 Roche Products Ltd Peptides of phosphonic and phosphinic acids
GB1585275A (en) * 1976-07-21 1981-02-25 Roche Products Ltd Peptide derivatives of phosphonic and phosphinic acids
US4179464A (en) * 1977-11-14 1979-12-18 Schultz Robert J Preparation of N-(phosphonoacetyl)-L-aspartic acid
EP0002039A1 (en) * 1977-11-19 1979-05-30 Ciba-Geigy Ag Phosphonous acid derivatives, processes for their preparation and their use in combating microorganisms
CA1108125A (en) * 1977-12-23 1981-09-01 Frank R. Atherton Olgiopeptide derivatives of phosphonic acid
US4178306A (en) * 1978-08-10 1979-12-11 Parsons Jack L Preparation of N-(phosphonoacetyl)-L-aspartic acid
US4154759A (en) * 1978-08-10 1979-05-15 Henryk Dubicki Preparation of N-(phosphonoacetyl)-L-aspartic acid
DE2966111D1 (en) * 1978-10-05 1983-10-06 Ciba Geigy Ag Process for influencing plant growth
US4331591A (en) * 1978-10-05 1982-05-25 Ciba-Geigy Corporation Chemical process for the production of α-aminophosphonic acids and peptide derivatives
EP0026867A1 (de) * 1979-09-28 1981-04-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Peptidylphosphonsäuren, deren Herstellung und Verwendung und sie enthaltende pharmazeutische Präparate
JPS5831992A (ja) * 1981-08-19 1983-02-24 Kyowa Hakko Kogyo Co Ltd 新規生理活性物質k−4およびその製造法
JPS57156498A (en) * 1981-03-20 1982-09-27 Kyowa Hakko Kogyo Co Ltd Novel physiologically active substance k-26
JPS5885897A (ja) * 1981-11-17 1983-05-23 Kyowa Hakko Kogyo Co Ltd 光学活性な1−アミノ−2−(4−ヒドロキシフエニル)エチルホスホン酸およびその誘導体
EP0103867B1 (en) * 1982-09-17 1986-12-17 Kyowa Hakko Kogyo Co., Ltd. Phosphorus-containing peptide derivative
US4463092A (en) * 1982-09-27 1984-07-31 Eli Lilly And Company Process for production antibiotic A53868
US4482488A (en) * 1982-09-27 1984-11-13 Eli Lilly And Company Antibiotic A53868 and process for production thereof
PT77368A (en) * 1982-09-27 1983-10-01 Lilly Co Eli Improved process for preparing immunomodulating agents or rela-ting there to
ATE50999T1 (de) 1985-06-11 1990-03-15 Ciba Geigy Ag Mikrobizide mittel.
FR2584077B1 (fr) * 1985-06-28 1988-07-08 Irceba L-di ou tripeptides possedant une activite biologique utilisable en medecine humaine et veterinaire, procede pour leur obtention et medicament en contenant
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
WO1989007940A1 (en) * 1988-03-03 1989-09-08 E.R. Squibb & Sons, Inc. 1,2-hydroxy phosphonates and derivatives thereof
WO1990000399A1 (en) * 1988-07-08 1990-01-25 Smithkline Beckman Corporation Retroviral protease binding peptides
US5468732A (en) * 1989-02-16 1995-11-21 Pfizer Inc. Phosphorus containing renin inhibitors
WO1990009172A1 (en) * 1989-02-16 1990-08-23 Pfizer Inc. Phosphorus containing renin inhibitors
US5321153A (en) * 1992-06-15 1994-06-14 Monsanto Company Process for making chiral alpha-amino phosphonates selected novel chiral alpha-amino phosphonates
US5473092A (en) * 1992-11-20 1995-12-05 Monsanto Company Synthesis of optically-active phosphono analogs of succinates
GB0022556D0 (en) * 2000-09-14 2000-11-01 Oxoid Ltd Improvements in or relating to selective agents for biological cultures
AU2001286121A1 (en) * 2000-09-18 2002-04-02 Newcastle Upon Tyne Hospitals Nhs Trust Selective growth media

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3893992A (en) * 1970-11-19 1975-07-08 Rohm & Haas N-acylated peptides of amino aromatic sulfonic acids and their derivatives
GB1445087A (en) * 1972-11-08 1976-08-04 Ici Ltd Preparing n-phosphonomethylglycine and nitrile intermediates therefor
US3954860A (en) * 1973-08-06 1976-05-04 Monsanto Company Phosphorous compounds
US3969398A (en) * 1974-05-01 1976-07-13 Monsanto Company Process for producing N-phosphonomethyl glycine

Also Published As

Publication number Publication date
LU74249A1 (ja) 1977-08-03
FI760084A (ja) 1976-07-28
AR218850A1 (es) 1980-07-15
NL7600539A (nl) 1976-07-29
BR7600449A (pt) 1976-08-31
PT64743A (en) 1976-02-01
NO146429C (no) 1982-09-29
AU1035476A (en) 1977-07-21
CH624965A5 (ja) 1981-08-31
SE7710045L (sv) 1977-09-07
FR2298335B1 (ja) 1980-06-20
JPS598278B2 (ja) 1984-02-23
FR2298335A1 (fr) 1976-08-20
PL99096B1 (pl) 1978-06-30
ES444622A1 (es) 1977-10-16
CH623829A5 (ja) 1981-06-30
PT64743B (en) 1978-01-04
DK143755B (da) 1981-10-05
DK29576A (da) 1976-07-28
SE424328B (sv) 1982-07-12
NL177021C (nl) 1985-07-16
CA1065857A (en) 1979-11-06
DE2602193C2 (de) 1982-07-08
ATA49276A (de) 1980-03-15
AT359217B (de) 1980-10-27
FI61032B (fi) 1982-01-29
NO146429B (no) 1982-06-21
DD123756A5 (ja) 1977-01-12
SE7600731L (sv) 1976-07-28
FI61032C (fi) 1982-05-10
DE2602193A1 (de) 1976-07-29
PH16560A (en) 1983-11-18
IE42466L (en) 1976-07-27
IL48835A (en) 1979-05-31
AU502919B2 (en) 1979-08-16
IE42466B1 (en) 1980-08-13
US4016148A (en) 1977-04-05
JPS5198223A (ja) 1976-08-30
NL177021B (nl) 1985-02-18
NO760231L (ja) 1976-07-28
IL48835A0 (en) 1976-03-31
DOP1976002544A (es) 1982-11-29
HU176800B (en) 1981-05-28
GR58609B (en) 1977-11-10

Similar Documents

Publication Publication Date Title
DK143755C (da) Analogifremgangsmaade til fremstilling af peptidphosphonsyrederivater eller salte deraf
DK145339C (da) Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf
DK145119C (da) Analogifremgangsmaade til fremstilling af phenolethere eller syreadditionssalte deraf
DK144942C (da) Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salte
DK149597C (da) Analogifremgangsmaade til fremstilling af calcitoninanaloge hentriaconpeptidderivater eller farmaceutisk acceptable syreadditionssalte eller komplekser deraf
DK149594C (da) Analogifremgangsmaade til fremstilling af dipeptidderivater eller syreadditionssalte heraf
DK154939C (da) Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DK154654C (da) Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf
DK149609C (da) Analogifremgangsmaade til fremstilling af hydroxyamino-alkan- eller -alkenphosphonsyrederivater eller estere eller salte deraf
DK151330C (da) Analogifremgangsmaade til fremstilling af aminoalkoholderivater eller farmaceutiske acceptable salte deraf
DK157079C (da) Fremgangsmaade til fremstilling af 7beta-amino-3-cephem-3-ol-4-carboxylsyreforbindelser eller salte deraf
DK149230C (da) Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf
DK144127C (da) Analogifremgangsmaade til fremstilling af lysergsyre- eller 9,10-dihydrolysergsyreamider eller syreadditionssalte deraf
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK155433C (da) Analogifremgangsmaade til fremstilling af aminosyrederivater eller fysiologisk acceptable salte deraf
DK143278C (da) Analogifremgangsmaade til fremstilling af n-(r-tetrahydrofurfuryl)-noroxymorphon eller syreadditionssalte deraf
DK143105C (da) Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf
DK153759C (da) Analogifremgangsmaade til fremstilling af prostansyrederivater
DK148019C (da) Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf
DK147577C (da) Analogifremgangsmaade til fremstilling af 2-phenyl-bicyclooctan- eller -octenaminer eller farmaceutisk acceptable syreadditionssalte deraf
DK143844C (da) Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller salte deraf
DK146127C (da) Analogifremgangsmaade til fremstilling af 5-(2-hydroxy-n-propoxy)-4-oxo-8-n-propyl-4h-1-benzopyran-2-carboxylsyre eller salte eller estre deraf
DK144034C (da) Analogifremgangsmaade til fremstilling af alkanophenon-0-(2-aminoethyl)-oximforbindelser eller salte deraf
DK144376C (da) Analogifremgangsmaade til fremstilling af bis-penicillanoyloxy-alkaner eller salte deraf
DK141068C (da) Analogifremgangsmaade til fremstilling af indolkinolizidinderivater eller salte eller optisk aktive isomerer deraf

Legal Events

Date Code Title Description
PBP Patent lapsed